Dendrite Appoints Peter Ladell and Peter Tombros to Board of Directors; Appointments to Bring Significant Pharmaceutical Leadership Experience to Dendrite Board.BEDMINSTER, N.J. -- Dendrite dendrite: see nervous system; synapse. International, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : DRTE DRTE Defence Research Telecommunications Establishment ), today announced the appointments of Peter Ladell and Peter Tombros to the Company's Board of Directors. The appointments, which become effective October 1, 2005, will bring more than 70 years of combined pharmaceutical leadership experience to the Dendrite Board. Mr. Ladell served as the Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. of Hoechst Marion Roussel from 1997 until the company's December 1999 merger with Rohne-Poulenc Rorer to form Aventis Pharmaceuticals. Mr. Ladell subsequently served as a member of the Aventis Executive Committee until his retirement in 2001. During his 35 year tenure at Hoechst Marion Roussel, and its predecessors, Mr. Ladell served in several other senior leadership positions, including President and Chief Executive Officer, Hoechst Marion Roussel, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. and President, Marion Merrell Dow (Direct OverWrite) See magneto-optic disk. Europe. Mr. Tombros is the Chairman and Chief Executive Officer of VivoQuest, Inc., a drug discovery company based in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . From 1994 to 2001, he was President and Chief Executive Officer of bio-pharmaceutical company Enzon, Inc. Prior to Enzon, Mr. Tombros spent 25 years with Pfizer, Inc., serving in various leadership roles, including Executive Vice President, Pfizer Pharmaceuticals; Senior Vice President, General Manager, Roerig Division; and Vice President, Marketing, Pfizer Laboratories Division. "I am extremely pleased to welcome Mr. Ladell and Mr. Tombros to our Board. The Company will benefit from their leadership and deep pharmaceutical industry knowledge," said Dendrite Chairman and Chief Executive Officer, John Bailye. About Dendrite Founded in 1986, Dendrite International Inc., (NASDAQ: DRTE) provides award-winning sales, marketing, clinical and compliance solutions and services to global pharmaceutical and other life sciences companies. With clients in more than 50 countries, including the world's top 20 pharmaceutical companies, Dendrite strives to be the first source for expert promotional and sales effectiveness solutions. For more information, please visit www.dendrite.com. Dendrite and the Dendrite logos are trademarks and/or registered trademarks of Dendrite International, Inc. All other names are trademarks and/or registered trademarks of their respective owners. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion